RHINOCORT ALLERGY SPRAY OTC
Generic Name and Formulations:
Budesonide 32mcg; per nasal spray; scent- and alcohol-free.
McNeil Consumer Healthcare
Indications for RHINOCORT ALLERGY SPRAY:
To relieve symptoms of seasonal or perennial allergic rhinitis.
Adults and Children:
<6yrs: not recommended. 6–<12yrs: initially 1 spray in each nostril once daily; increase to 2 sprays per nostril once daily if no improvement; reduce to 1 spray in each nostril once daily when symptoms improve. ≥12yrs: use 2 sprays per nostril once daily; reduce to 1 spray in each nostril once daily when symptoms improve.
Do not use for treating the common cold or use more than recommended. Avoid eyes or mouth. Recent nose ulcers or surgery. Nose injury that has not healed. Eye infection. Glaucoma. Cataracts. Re-evaluate if no improvement after 2 weeks. Discontinue if exposed to chickenpox, measles, or tuberculosis, have symptoms of an infection (eg, persistent fever), change in vision, severe or frequent nosebleeds. Children 6–<12yrs: monitor and re-evaluate if treatment requires >2 months per year. Pregnancy. Nursing mothers.
Concomitant other steroid drugs for asthma, allergies, or skin rash.
Reduced growth velocity in children.
Spray—5mL (60 sprays), 8.4mL (120 sprays)
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- ADA Updates Guidelines for Cardiovascular Risk Management in Diabetes
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine
- Intensive Lifestyle Interventions Cut Long-Term Disability in Type 2 Diabetes